
i am attaching a screenshot of a work email confirming that it is being implemented, despite the source i listed saying it has been paused.

i am attaching a screenshot of a work email confirming that it is being implemented, despite the source i listed saying it has been paused.
This appears to contain the actual text of SF 383.
You linked to a page arguing against it, but the main argument appears to be that the mandated copay of ~$10.50ish is problematic and that it limits the rights of employers to promote a pharmacy over another. Is that correct?
(There seems to be more to the bill than that of course.)